ADAR1 Capital Management »

Omniab shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Omniab (OABI) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Omniab

Tip: Access up to 7 years of quarterly data

All positions including Omniab held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omniab by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 478k 6.17

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Omniab

Henderson Group
Vanguard Group
William Blair Investment Management
Chicago Capital
Rice Hall James & Associates
Private Management Group
Dimensional Fund Advisors
Millennium Management
St. Denis J. Villere & Co
First Sabrepoint Capital Management
Orchard Capital Managment
Kornitzer Capital Management
Impax Asset Management Group
Charles Schwab Investment Management
Woodstock Corp

View all funds holding Omniab